Cortisol Blood Test: Normal Ranges & Causes | Peptide Chats
Research information only. Not medical advice. 18+ only. Not FDA-approved for human therapeutic use.

Cortisol blood test

Cortisol. Also called: Hydrocortisone, Compound F, Serum cortisol, Salivary cortisol, Urine free cortisol

Biomarker guideLast updated: October 29, 2026

Cortisol is the body's main stress steroid, made by the adrenal glands. It follows a strong daily rhythm, highest in the morning and lowest around midnight, so the time and type of sample (blood, saliva or 24-hour urine) decide which range applies.

LOINC 2143-6Hormones

At a glance

What it measuresCortisol, the main glucocorticoid made by the adrenal glands, in blood, saliva or a 24-hour urine collection.
SampleBlood (serum) at a set time, saliva collected at home at set times, or all urine over 24 hours.
Typical adult range (blood)Labcorp: AM 6.2-19.4 µg/dL, PM 2.3-11.9 µg/dL. Quest: 7-9 a.m. 4.0-22.0, 3-5 p.m. 3.0-17.0 µg/dL.
Common reasons it reads highMorning sampling, stress or illness, hard exercise, oral estrogen and pregnancy, prednisolone (cross-reacts in assays) and Cushing's syndrome.
Peptides that move itRaised after a dose by Hexarelin, GHRP-2, GHRP-6, Ghrelin, Corticotropin-Releasing Hormone (CRH) and Cosyntropin. Lowered by Pasireotide in Cushing's disease.
Lab codeLOINC 2143-6 (Labcorp 004051, Quest 367); saliva 2142-8; 24-hour urine 2147-7

What is Cortisol?

Cortisol is the main human glucocorticoid. It is made from cholesterol in the adrenal cortex and broken down mainly by the liver. It is the only hormone routinely measured in blood, urine and saliva.

Labcorp uses the blood test to diagnose adrenal insufficiency (including Addison's disease) and adrenal overactivity, including Cushing's syndrome. Faults anywhere in the hypothalamic-pituitary-adrenal axis change cortisol levels.

Sources: [1] [2]

How it is made and regulated

Where it is made

The pituitary hormone ACTH stimulates the adrenal cortex to secrete cortisol; the ACTH label notes that prolonged large doses cause continuous high cortisol output. ACTH is in turn driven by the hypothalamus, so a problem at any of the three levels can change cortisol.

Sources: [3] [2]

What controls it

Cortisol follows a daily rhythm, and in most healthy people waking up triggers a burst of secretion (the cortisol awakening response). Levels fall through the day to a low point around midnight; people with Cushing's syndrome often lose that late-night low.

Sources: [4] [5] [6] [2]

How it travels in the blood

Most blood cortisol is bound to proteins: 80-90% to corticosteroid-binding globulin (CBG) and the rest mostly to albumin, with free cortisol under 6% of the total. A total cortisol test measures both, so anything that raises CBG, such as pregnancy, contraceptives or estrogen therapy, raises the result.

Sources: [7] [8] [2]

How long it lasts

Cortisol is cleared mainly by the liver. People with more body fat made more cortisol per day, but they also cleared it faster, so their free cortisol stayed the same.

Sources: [1] [9]

What it does

Cortisol raises blood sugar by promoting glucose production in the liver and blunting insulin's action in muscle and fat, protecting fuel for the brain during stress. Too much over time causes high blood sugar and insulin resistance.

Sources: [10]

Reference ranges

There is no single cortisol range. Each sampling method has its own: morning and afternoon blood, saliva at set times of day, and 24-hour urine. Both labs publish a range for every method; the urine sets are in µg per 24 hours.

Labcorp (test 004051)

Method: Electrochemiluminescence immunoassay (ECLIA), serum. Labcorp test page (retrieved October 29, 2026).

GroupRange (µg/dL)
Morning (AM; Labcorp asks for 8 a.m.)6.2-19.4
Afternoon (PM; Labcorp asks for 4 p.m.)2.3-11.9

Blood (serum). Labcorp asks for blood drawn at 8 a.m. and 4 p.m. to show the normal daily swing.

Quest Diagnostics (test 367)

Method: Immunoassay (IA), serum. Quest Diagnostics test page (retrieved October 29, 2026).

GroupRange (µg/dL)
Adults, 8 a.m. specimen (7-9 a.m.)4.0-22.0
Adults, 4 p.m. specimen (3-5 p.m.)3.0-17.0
Children and teens
GroupRange (µg/dL)
Premature newborns (31-35 weeks), 0-3 days, a.m. or p.m.15.0 or below
Term newborns, 0-3 days, a.m. or p.m.14.0 or below
4 days to 1 monthNot established
2-11 months, a.m.3.0-23.0
1-17 years, a.m.3.0-25.0
1-17 years, p.m.3.0-17.0

Blood (serum). Quest does not recommend this assay for people taking prednisone or prednisolone, which cross-react with its antibody.

Labcorp (test 500179)

Method: High-pressure liquid chromatography/tandem mass spectrometry (HPLC/MS-MS), saliva. Labcorp test page (retrieved October 29, 2026).

GroupRange (µg/dL)
8:00 a.m.0.025-0.600
NoonBelow 0.010 to 0.330
4:00 p.m.0.010-0.200
Midnight (late night)Below 0.010 to 0.090

Saliva, collected in a Salivette tube at the prescribed time. One range for children and adults.

Quest Diagnostics (test 19897)

Method: Chromatography/mass spectrometry, saliva. Quest Diagnostics test page (retrieved October 29, 2026).

GroupRange (µg/dL)
8-10 a.m.0.04-0.56
Noon-2 p.m.0.21 or below
4-6 p.m.0.15 or below
10 p.m.-1 a.m. (late night)0.09 or below

Saliva. Collect at least 60 minutes after brushing teeth, eating or taking oral medicine, and 10 minutes after rinsing with water. Quest uses late-night salivary cortisol to screen for Cushing syndrome.

Labcorp (test 004432)

Method: LC/MS-MS, 24-hour urine free cortisol. Labcorp test page (retrieved October 29, 2026).

GroupRange (µg/24 h)
Men, 18 to 80 years5-64
Women, 18 to 80 years6-42
Over 80 years3-49
Children and teens
GroupRange (µg/24 h)
2 to 5 years2-16
Boys, 6 to 11 years4-28
Girls, 6 to 11 years4-24
12 years4-36
Boys, 13 to 17 years6-45
Girls, 13 to 17 years6-42

24-hour urine, reported in µg per 24 hours. Labcorp gives no range from birth to 1 year.

Quest Diagnostics (test 11280)

Method: Liquid chromatography/tandem mass spectrometry (LC/MS/MS), 24-hour urine. Quest Diagnostics test page (retrieved October 29, 2026).

GroupRange (µg/24 h)
Adults4.0-50.0
Children and teens
GroupRange (µg/24 h)
1-4 years0.9-8.2
5-9 years1.0-30.0
10-13 years1.0-45.0
14-17 years3.0-55.0

24-hour urine, reported in µg per 24 hours. Quest notes that the ranges do not apply to random urine samples; record the full 24-hour volume.

Saliva and urine tests at both labs use mass spectrometry (LC-MS/MS); the blood tests use immunoassays. Ranges differ between methods and labs, so compare a result only with the range for the same test. Quest's ranges are for its East region.

Units: Blood and saliva cortisol are reported in µg/dL (mcg/dL); 24-hour urine free cortisol is reported per day (µg/24 hours). Some labs report nmol/L: 18 µg/dL is about 500 nmol/L. [14]

Sources: [2] [11] [6] [5] [12] [13]

Is there an "optimal" range?

There is no "optimal" cortisol. The useful questions are whether it is too high at the wrong time of day, or too low when it should be high.

Read cortisol against the range for the same test and time

Labcorp AM 6.2-19.4 µg/dL; PM 2.3-11.9 µg/dL

Labcorp and Quest

Both labs publish separate ranges by time of day and specimen, because a normal morning value would be high at night and a normal night value low in the morning.

Sources: [2] [11] [5]

Stimulation-test cut-offs depend on the assay

18 µg/dL classic; about 14.5-14.8 µg/dL with newer assays

Javorsky and colleagues, 110 patients tested for adrenal insufficiency (2021)

The usual pass mark after cosyntropin (18 µg/dL, about 500 nmol/L) was set with older assays. With newer, more specific assays the equivalent 30-minute cut-offs were 14.5-14.8 µg/dL; using 18 labelled up to 32% of patients as adrenally insufficient.

Sources: [14]

"Adrenal fatigue" cortisol curves are not a diagnosis

Systematic review (Cadegiani and Kater, 2016)

The review found conflicting results across studies of salivary rhythms and awakening responses in "adrenal fatigue", and concluded there is no substantiation that it is an actual medical condition.

Sources: [15]

What raises it

FactorHowHow much
Time of day (morning) and wakingPhysiologyCortisol peaks in the morning, with a burst after waking, and falls through the day. A morning sample is expected to read much higher than an afternoon one.Labcorp AM 6.2-19.4 vs PM 2.3-11.9 µg/dL [4] [2]
Stress and illnessPhysiologyPhysical and emotional stress activate the HPA axis. Labcorp notes that severe stress can raise cortisol, and poor sleep quality heightens the cortisol response to stress.No published magnitude [2] [16]
Hard exerciseLifestyleExercise raises cortisol once intensity passes a threshold; easy exercise does not.30 minutes at 60% and 80% of VO2max: +39.9% and +83.1%; 40%: +5.7% (12 trained men) [17] [18]
Oral estrogen, contraceptives and pregnancyHormoneEstrogen raises the binding protein CBG, so total cortisol rises even though free cortisol may not. Labcorp lists pregnancy, contraceptives and estrogen therapy as causes of elevated results.Case report: morning cortisol 61 and 55 mcg/dL on an estrogen-containing pill (normal range 8-25) [2] [19] [7]
Prednisone and prednisolone (assay interference)MedicationThese steroids cross-react with cortisol immunoassays and give falsely high results. Quest does not recommend its assay during prednisone or prednisolone therapy.No published magnitude [2] [11]
Cushing's syndromeConditionToo much cortisol from a pituitary or adrenal tumor, or from steroid medicines. Late-night salivary cortisol is often high because the normal night-time low is lost.No published magnitude [11] [5] [20]
GH-releasing and stimulating peptidesPeptideGhrelin-receptor agonists, CRH and cosyntropin raise cortisol after a dose. See the peptide table below.GHRP-6 1 µg/kg IV: cortisol 257.0 to 367.0 nmol/l (peak) in 7 controls [21]

What lowers it

FactorHowHow much
Adrenal insufficiencyConditionDamage to the adrenal glands (primary, Addison's disease) or too little ACTH (secondary) lowers cortisol. Long-term glucocorticoid medicines can also suppress the axis.No published magnitude [11] [22] [23]
Time of day (late evening and night)PhysiologyCortisol reaches its low point around midnight, which is why late-night saliva is used to screen for Cushing's syndrome.Late-night saliva: Labcorp below 0.010 to 0.090 µg/dL [6] [5]
Regular high-intensity interval trainingLifestyleA review of exercise studies found that regular high-intensity interval training lowers basal cortisol, while a single bout of endurance exercise raises it.No published magnitude [18]
Pasireotide in Cushing's diseasePeptidePasireotide acts on the pituitary tumor to cut ACTH and cortisol. See the peptide table below.Urinary free cortisol normal at month 6 in 12 of 82 (600 µg) and 21 of 80 (900 µg) patients [24]

Peptides that affect Cortisol

How each peptide in our library has been shown to affect cortisol, strongest evidence first. Most GH-releasing peptides raise cortisol briefly after each dose; the size column says whether the data are a single dose (acute) or repeated dosing, and which sample was used. In rodents the equivalent hormone is corticosterone. "No clear effect" means cortisol was measured and did not change; "Unclear" means the results conflict or the source gives no cortisol result.

PeptideEffect on CortisolSize of effectEvidence
AdrenomedullinRaisesPlasma cortisol, acute: seven healthy volunteers on a low-salt diet, adrenomedullin 4 pmol/min/kg vs vehicle (crossover) - augmented the cortisol response to an ACTH infusion (P<0.01); unstimulated cortisol not reportedIn healthy people, an adrenomedullin infusion boosted the cortisol response to ACTH. Its effect on resting cortisol is unknown. [25]Human trials
Corticotropin-Releasing Hormone (CRH)RaisesPlasma cortisol, acute single IV dose: ovine CRH 1 microgram/kg in 21 healthy children - peak cortisol 14.3 micrograms/dl (girls) and 16.6 micrograms/dl (boys); responses did not differ from adultsCRH reliably raises cortisol within an hour; this is the basis of the CRH stimulation test. [26]Human trials
DesmopressinRaisesPlasma cortisol, acute single IV dose: 10 microg produced marked ACTH and cortisol rises in Cushing disease but not pseudo-Cushing states; in healthy subjects, 10 and 15 microg (not 5 microg) raised cortisol more than saline, with 11/18 "responders" at 10 microgDesmopressin raises cortisol strongly in Cushing disease (the basis of the desmopressin test) and modestly in about half of healthy people. [27] [28]Human trials
GhrelinRaisesSerum cortisol, acute infusion. Fifteen healthy young men, ghrelin 5 pmol/kg per minute for 180 min (placebo-controlled crossover): a 1.6-fold increase in cortisol (P < 0.05). IV ghrelin (1 or 3 mcg/kg) also raised serum cortisol in alcohol-dependent adultsGhrelin raises cortisol acutely; a review of 121 human studies calls the evidence strong. No data on repeated dosing. [29] [30] [31]Human trials
GHRP-2RaisesSerum cortisol, acute single IV dose. 2.0 microg/kg IV in 7 young adults: cortisol peak 181.2 ± 14.1 microg/l; 1-2 micrograms/kg IV in 6 young adults raised cortisol similarly to hCRH. Used diagnostically: a peak cortisol cut-off of 11.6 μg/dL predicted secondary hypoadrenalism (88.9% specificity, 89.7% sensitivity)GHRP-2 raises cortisol within an hour of a dose, strongly enough to be used as an adrenal test. No sustained-dosing data. [32] [33] [34]Human trials
GHRP-6RaisesSerum cortisol, acute single IV dose. 7 controls, 1 ug/kg IV: cortisol 257.0 ± 42.9 to 367.0 ± 50.8 nmol/l (peak). Cushing's disease, 2 microg/kg IV: 583.0 ± 90.8 to 1013.4 ± 194.6 nmol/lGHRP-6 raises cortisol acutely, more so in Cushing's disease. No repeated-dosing data in people. [21] [35]Human trials
GlucagonRaisesSerum cortisol, acute single dose (glucagon stimulation test). Six healthy men, glucagon 1 mg s.c.: cortisol 256 ± 80 to a peak of 481 ± 164 nmol/l (P < 0.01), ACTH-dependentA glucagon injection raises cortisol for a few hours, which is why it is used as a pituitary-adrenal test. [36]Human trials
HexarelinRaisesRaises cortisol per dose; the response attenuates over 16 weeks. Serum cortisol, acute: 2.0 micrograms/kg IV in normal subjects (6 men and 6 women), 110.0 ± 31.6 to 135.9 ± 51.0 micrograms/L (P < 0.01). Over 16 weeks of 1.5 micrograms/kg s.c. twice daily, the cortisol response (AUC) fell from 1506 to 1222 nmol/l/h and recovered to 1586 four weeks after stopping, with no change in 24-h urinary free cortisol or basal cortisolEach injection raises cortisol briefly, but with 16 weeks of use the response shrinks rather than building up. This is not a sustained elevation. [37] [38] [39]Human trials
LysipressinRaisesPlasma cortisol (RIA) sampled −15 to 120 min after 10 IU lysine-vasopressin i.m. (acute stimulation test, after 1 mg dexamethasone the night before): cortisol rose in Cushing's disease; dexamethasone-suppressed controls showed no responseDiagnostic stimulation-test data only: an injection raised cortisol in Cushing's disease, but not in dexamethasone-suppressed controls. No data on everyday use. [40]Human trials
MK-677 (Ibutamoren)RaisesAcute and 7-day courses: no change in 24-h plasma total and free cortisol or 24-h urinary free cortisol (9 young men, 5 and 25 mg) or in the serum cortisol response (8 adults, 25 mg). Over 2 years: 65 adults aged 60-81 on 25 mg daily, cortisol up 47 nmol/L (CI, 28 to 71; 1.7 µg/dL) (P = 0.020)No cortisol change in acute or 7-day courses; a modest rise appeared only with 2 years of daily use in older adults. [41] [42] [43]Human trials
UrocortinRaisesPlasma cortisol, acute: 8 healthy men given 50 μg urocortin-1 IV over 1 h: 15.6 vs 7.7 μg/dL with placebo (432 vs 213 nmol/L). Pegylated UCN1 in mice: 4-6-fold rise in serum corticosterone. No repeated-dosing human dataRoughly doubles cortisol after a single infusion in healthy men, via the CRH-1 receptor. [44] [45]Human trials
DermorphinLowersPlasma cortisol, acute: normal men, dermorphin 5.5 micrograms/kg/min IV for 30 min - cortisol fell (P < 0.02); naloxone pretreatment prevented the fall; no values in the abstractOne small 1983 study: the opioid peptide lowered cortisol through opioid receptors. [46]Human trials
Erythropoietin (EPO)LowersPlasma cortisol, sustained dosing. Hemodialysis patients, 17 on EPO vs 17 without, followed 12 months: cortisol (and ACTH) fell significantly on EPO, mostly within the first 6 months (no values in the abstract)One small, non-randomized study of kidney-failure patients found long-term EPO lowered cortisol. Not studied in healthy people. [47]Human trials
InsulinLowersSerum total and calculated free cortisol, sustained IV insulin. Four hundred fifty-one critically ill surgical ICU patients randomized to intensive insulin (normoglycemia) vs conventional care: cortisol equally high on admission, lower thereafter with intensive insulinOnly shown in intensive care with IV insulin to tight glucose targets; not relevant evidence for routine insulin use. [48]Human trials
LiraglutideLowersPlasma cortisol (timing not stated), 20 adults with obesity and psoriasis on liraglutide 3 mg for 3 months (sustained, uncontrolled): 12 ± 3.1 → 11.6 ± 2.2 µg/dL (p = 0.04)A statistically significant but very small cortisol drop in one small uncontrolled study. [49]Human trials
PasireotideLowers24-hour urinary free cortisol (plus serum and salivary cortisol). Phase 3 RCT, 162 adults with Cushing's disease, 600 or 900 µg s.c. twice daily (sustained): median UFC down ~50% by month 2 and stable through 12 months; normal UFC at month 6 in 12 of 82 (600 µg) and 21 of 80 (900 µg)Lowers cortisol in Cushing's disease; this is the approved use. [24] [50]Human trials
AnamorelinNo clear effectBlood cortisol (specimen not stated), repeated daily dosing: 32 healthy volunteers, anamorelin 25, 50 and 75 mg daily vs placebo; cortisol was on the measured panel and all mean hormone levels stayed within the normal rangeIn healthy volunteers, anamorelin raised GH without a meaningful cortisol change. [51]Human trials
Angiotensin IIINo clear effectPlasma cortisol, acute: 30-minute IV infusion in 6 normal subjects and 24 patients with essential hypertension - cortisol did not change while aldosterone roseA short angiotensin III infusion raised aldosterone but not cortisol in people. [52]Human trials
Delta Sleep-Inducing Peptide (DSIP)No clear effectPlasma cortisol, acute single doses. Eleven healthy men, DSIP 25 nmol/kg IV vs saline (crossover): plasma cortisol unaffected (urinary cortisol also unchanged). IV infusions of 3 and 4 mg did not change CRH-stimulated (n = 5 per condition) or meal-related (10 men) cortisolIn healthy men, single doses of DSIP did not change cortisol. A rat study saw lower stimulated corticosterone, but the human studies did not reproduce it. No repeated-dosing data. [53] [54] [55]Human trials
IGF-1 (Insulin-Like Growth Factor 1)No clear effectSerum cortisol, single dose. 6 young women, rhIGF-I 20 microg/kg s.c.: cortisol unchanged over the following 180 min, and the CRH-stimulated cortisol peak was 181.1 microg/l with rhIGF-I vs 177.5 microg/l withoutA single IGF-1 dose did not change resting or stimulated cortisol in a small study. [56]Human trials
MacimorelinNo clear effectSerum cortisol sampled at baseline, 30, 45, 60, 90 and 120 min after a single oral dose (0.5 and 0.75 mg/kg) in 28 healthy volunteers (acute): no changeThe diagnostic ghrelin agonist did not change cortisol in healthy volunteers. [57]Human trials
NafarelinNo clear effectPlasma cortisol, serial samples over 5 h on day 1 and after 1 and 3 months of intranasal nafarelin 200 µg twice daily in 11 women aged 26-43 (sustained): unchangedThree months of nafarelin did not change cortisol. [58]Human trials
Thyrotropin-Releasing Hormone (TRH)No clear effectPlasma cortisol, acute IV bolus: no rise in 15 control subjects (slight decrease); a paradoxical rise (delta max 8.0 μg/100 mL, 53%) only in 3 of 6 patients with Cushing's disease. Overnight TRH infusion in 20 critically ill patients: no effect on serum cortisolDoes not raise cortisol in people without Cushing's disease; the paradoxical rise is a diagnostic quirk of pituitary tumors. [59] [60]Human trials
Urocortin-2No clear effectBlood cortisol, acute infusions in heart-failure patients: systematic review of clinical studies found urocortin 2 infusions did not raise cortisolDoes not activate the stress-hormone axis in human infusion studies (it acts on CRH-2, not CRH-1, receptors). [61]Human trials
Angiotensin IIUnclearSerum cortisol in normal men: during prolonged infusions on a normal-sodium diet, 9 a.m. cortisol first fell and then rose; on a low-sodium diet it rose slightly. In another study plasma ACTH fell during infusion in six healthy subjectsAngiotensin II both suppresses ACTH and stimulates the adrenal, so cortisol can fall or rise depending on timing and salt intake. [62] [63]Human trials
Atrial Natriuretic PeptideUnclearStimulated plasma cortisol, acute, in healthy men: intranasal ANP 1 mg halved the cortisol response to insulin hypoglycemia (18 men); IV ANP at high physiological levels did not change the CRH response (six men); IV ANP 4.4 microg/min first blunted and then, in the third hour, enhanced ACTH and cortisolResults depend on route and timing: intranasal ANP dampened stress-stimulated cortisol, IV ANP had no effect or a delayed rise. [64] [65] [66]Human trials
Beta-EndorphinUnclearSerum/plasma cortisol, acute IV infusions in small studies: lowered baseline cortisol in six healthy men and blunted the response to ACTH (integrated response 163 vs 282 microgram/dl x min); no cortisol change in depressed patients or methadone withdrawal, and no change in the response to releasing hormones in 7 volunteersSmall, older infusion studies disagree; very high blood levels may blunt cortisol. [67] [68] [69] [70]Human trials
CortexinUnclearBlood cortisol in patients with organic emotionally labile (asthenic) disorders: adding Cortexin to standard therapy "normalized" cortisol; the abstract gives no direction, values or sample sizeOne Russian study reports cortisol "normalized" with Cortexin, without numbers. [71]Human trials
Neuropeptide YUnclearNocturnal plasma cortisol after IV NPY (4 × 50 or 100 µg at 22.00-01.00, single night, acute): reduced in the second half of the night in young men; unchanged with 50 µg in depressed patients and their (older) controlsOne night of IV NPY lowered night-time cortisol in young men but not in a second study of depressed patients and controls. [72] [73]Human trials
OctreotideUnclearSerum cortisol. ACTH-dependent Cushing's syndrome (10 patients, 50-500 µg every 8 h for 24-72 h): fell into or below the normal range in 3 patients (sustained 2-72 weeks), no response in 6. Acromegaly (200 µg three times daily for 3 months): basal cortisol suppressed. Ectopic ACTH from small cell lung cancer (2 patients, 100 µg s.c.): paradoxical riseEffects on cortisol vary with the cause of excess ACTH; data come from small case series only. [74] [75] [76]Human trials
OxytocinUnclearSalivary cortisol fell after a single intranasal dose before a couple-conflict discussion (47 couples; F = 7.14, p = .011) and cue-induced cortisol fell with 80 IU twice daily for 7 days (20 people on opioid agonist therapy). IV oxytocin (30-120 mU/kg bolus, or overnight infusion) did not change morning or circadian ACTH and cortisol in normal menIntranasal oxytocin blunted stress-induced cortisol rises in two lab studies, but did not change baseline cortisol when given IV. [77] [78] [79]Human trials
Adrenocorticotropic Hormone (ACTH)RaisesPlasma cortisol: the Acthar Gel label states ACTH stimulates the adrenal cortex to secrete cortisol, and prolonged large doses cause continuous high cortisol output. A small gout study found cortisol no different from before at 24 hours after a doseRaising cortisol is how ACTH works. The rise is short-lived after a single dose; long, high-dose use keeps cortisol high. [3] [80]FDA label
CosyntropinRaisesPlasma cortisol, acute single 0.25 mg dose: stimulated plasma cortisol levels of less than 18 mcg/dL at 30- or 60-minutes post CORTROSYN injection are suggestive of adrenocortical insufficiency (label section 2.6)Cosyntropin is the standard adrenal stimulation test; raising cortisol is its purpose. [81] [82]FDA label
TesamorelinUnclearEgrifta SV label, verbatim. On pituitary hormones: "No clinically significant changes in the levels of other pituitary hormones, including thyroid-stimulating hormone (TSH), luteinizing hormone (LH), adrenocorticotropic hormone (ACTH) and prolactin, were observed in patients receiving EGRIFTA in clinical trials." On glucocorticoids: "GH inhibits 11β-hydroxysteroid dehydrogenase type 1 (11βHSD-1), a microsomal enzyme required for conversion of cortisone to its active metabolite, cortisol, in hepatic and adipose tissue. EGRIFTA SV stimulates GH production; therefore, patients receiving glucocorticoid replacement for previously diagnosed hypoadrenalism may require an increase in maintenance or stress doses following initiation of EGRIFTA SV." The label reports no cortisol measurement.The label's "no clinically significant changes" line is about ACTH and other pituitary hormones, not cortisol, and the label gives no cortisol result. People on steroid replacement may need higher doses. [83]FDA label
Apelin-13RaisesPlasma corticosterone (the rodent equivalent of cortisol), acute: male mice given pGlu-apelin-13 1 mg/kg into the brain ventricles - corticosterone 189.5% of saline controlsCentral apelin activated the stress-hormone axis in mice. Not tested in humans or with injections under the skin. [84]Animal studies
BPC-157RaisesAnimal (rats), mechanism study: after removal of one adrenal gland, BPC-157 10 µg or 10 ng/kg intragastric gave serum cortisol of 49.9 (µg dose) vs 19.9 nmol/L in controls at 15 min, still far below normal rats (the paper measured cortisol; rats mainly make corticosterone)Animal data only: in rats missing one adrenal gland, BPC-157 partly restored low cortisol, still well below normal. It has not been shown to raise cortisol in intact animals or in people. [85]Animal studies
C-Type Natriuretic PeptideRaisesPlasma cortisol, acute central infusion: conscious sheep (n = 7), CNP-22 5 micrograms/h into the brain ventricles for 3 h - transient cortisol rise after 30 min (p = 0.049) and a larger cortisol response to hemorrhage (p = 0.004)Central CNP activated the stress-hormone axis in sheep. No human data. [86]Animal studies
CapromorelinRaisesSerum cortisol, Beagle dogs, oral capromorelin for 7 days: cortisol rose after each dose and returned to baseline by 8 h; the rise was smaller on days 4 and 7 than on day 1In dogs, capromorelin briefly raises cortisol after each dose, and the effect fades with repeated dosing. No published human cortisol values. [87]Animal studies
DynorphinRaisesPlasma cortisol, acute single dose. Fetal lambs given dynorphin A1-13 0.5 mg/kg IV: cortisol peaked at 32.8 ± 9.0 ng/ml 15 min after the dose (P = .002), through a naloxone-insensitive (non-opioid) mechanismRaised cortisol acutely in fetal sheep. No human data. [88]Animal studies
Melanotan IIRaisesPlasma corticosterone (the rodent equivalent of cortisol) in conscious rats after intracerebroventricular MTII (acute): dose- and time-dependent rise, peak 30 min after injection; no human dataRaised the rodent stress hormone corticosterone when injected into the brain of rats. No human data. [89]Animal studies
Neurokinin ARaisesPlasma corticosterone (the rodent equivalent of cortisol) in rats after subcutaneous NKA 1 or 3 nmol/100 g (acute): transient rise at 30 min with the lower dose, at 30 and 60 min with the higher dose; ACTH unchanged (direct adrenal effect)Briefly raised the rodent stress hormone corticosterone by acting on the adrenal gland directly. No human data. [90]Animal studies
Orexin ARaisesPlasma corticosterone (the rodent equivalent of cortisol) in conscious rats after a single intracerebroventricular injection of orexin-A 10 µg (acute): peak 6.7-fold above basal at 30 minRaised the rodent stress hormone corticosterone when injected into the brain of rats. No human data. [91] [92]Animal studies
VasotocinRaisesFish only (fish use cortisol as their main stress steroid): ICV vasotocin in rainbow trout and exogenous vasotocin in African cichlids raised plasma cortisol; no values in the abstracts. No mammalian or human dataRaises cortisol in fish as part of a stress response. Not studied in mammals. [93] [94]Animal studies
Alpha-Melanocyte-Stimulating Hormone (α-MSH)LowersPlasma cortisol, acute central infusion in ovariectomized rhesus monkeys: alpha-MSH prevented the IL-1 alpha-induced rise (167% vs 91.7% of baseline) but not the CRF-induced rise (136% alone vs 121% with alpha-MSH)In monkeys, alpha-MSH blocked the cortisol rise from an inflammatory signal but not from CRF. No human data. [95]Animal studies
LeptinLowersPlasma corticosterone (the rodent equivalent of cortisol) in rats given systemic recombinant rat leptin (100 or 500 µg): lower at 240 and 300 min after a single dose (acute); no human cortisol dataIn rats a single systemic leptin dose lowered the rodent stress hormone corticosterone. No human data. [96]Animal studies
NociceptinLowersPlasma corticosterone (the rodent equivalent of cortisol) in mice 30 min after intracerebroventricular injection (acute): saline injection plus handling raised corticosterone by +250%; N/OFQ 1 µg blunted this riseBlunted the stress-induced corticosterone rise in mice when injected into the brain. No human data. [97]Animal studies
SelankLowersMale Wistar rats under restraint stress: Selank 80, 250 and 750 μg/kg i.p. 15 min before stress lowered the stress-raised corticosterone (the rodent equivalent of cortisol; serum). No values in the abstractIn stressed rats Selank blunted the stress hormone rise. No human cortisol data. [98]Animal studies
SemaxLowersMale Wistar rats under restraint stress: Semax (ACTH(4-7)-PGP) 5-450 μg/kg i.p. 12-15 min before stress lowered the stress-raised serum corticosterone (the rodent equivalent of cortisol). No values in the abstractIn stressed rats Semax blunted the stress hormone rise, despite being an ACTH fragment. No human cortisol data. [99]Animal studies
IpamorelinNo clear effectPlasma cortisol, acute dose, conscious swine: no ACTH or cortisol rise beyond that seen with GHRH, even at doses more than 200-fold the GH ED50 (GHRP-6 and GHRP-2 both raised cortisol)Unlike GHRP-2 and GHRP-6, ipamorelin did not raise cortisol in pigs. No published human cortisol data. [100]Animal studies
EpitalonUnclearFemale rhesus monkeys: Epithalon "normalized circadian rhythms of cortisol production" in old animals (no values in the abstract)One monkey study reports a normalised daily cortisol rhythm, not a simple rise or fall. No human data. [101]Animal studies
GalaninUnclearRats (corticosterone, the rodent equivalent): peripheral galanin raised plasma corticosterone dose-dependently in hypophysectomized rats; galanin injected into the hypothalamic PVN (1 microgram) inhibited corticosterone releaseRat results point in opposite directions depending on where galanin is given. No human data. [102] [103]Animal studies
Substance PUnclearAlbino rats, prolonged substance P dosing: plasma cortisol (as the abstract reports it; rats mainly make corticosterone) fell in intact rats but rose in pharmacologically altered rats. No values in the abstractDirection depends on the state of the stress axis in rats. No human data. [104]Animal studies
Urocortin-3UnclearPlasma corticosterone (the rodent equivalent of cortisol) in rats 30 min after ICV urocortin 3: lower at 1 and 2 μg, higher at 0.5 and 5 μgRat brain-injection data go both ways depending on dose. No human data. [105]Animal studies

What high or low results can mean

A high result

A high cortisol is most often explained by timing, stress, illness or estrogen. Persistently high cortisol at night, or too much over 24 hours, can mean Cushing's syndrome.

  • Morning sampling or recent waking
  • Stress, illness or poor sleep
  • Hard exercise
  • Oral estrogen, contraceptives or pregnancy
  • Prednisone or prednisolone (assay cross-reaction)
  • Cushing's syndrome

Next step: One high blood value is rarely enough. The Endocrine Society recommends starting with a test of high accuracy, such as urine cortisol, late-night salivary cortisol or a dexamethasone suppression test, and seeing an endocrinologist if it is abnormal.

Sources: [20] [2] [5]

A low result

A low morning cortisol can mean adrenal insufficiency, especially with fatigue, weight loss, low blood pressure or low sodium. A low afternoon or night value is normal.

  • Afternoon or night sampling
  • Adrenal insufficiency (Addison's disease)
  • Low ACTH from a pituitary problem
  • Suppression by steroid medicines

Next step: A low morning value is usually followed by a cosyntropin (ACTH) stimulation test, read with the cut-off for the lab's assay. Do not stop prescribed steroids to "fix" a result without medical advice.

Sources: [22] [14] [11]

How the test works

SampleBlood: Labcorp takes serum in a gel-barrier (preferred) or red-top tube. Saliva: a Salivette tube, collected 60 minutes or more after brushing teeth, eating or taking oral medicine. Urine: the full 24-hour collection, with its volume recorded; ranges do not apply to random urine.
FastingNeither Labcorp nor Quest lists a fasting requirement for cortisol. Timing matters far more than food.
TimingLabcorp asks for blood at 8 a.m. and 4 p.m. to show the daily swing, and the time of collection must be taken into account. Hard exercise and stress before the test raise cortisol. Labcorp asks people to stop high-dose biotin at least 72 hours before the sample.
Lab differencesBlood tests use immunoassays (Labcorp ECLIA on Roche cobas; Quest immunoassay), which can overestimate true cortisol and cross-react with prednisolone and other steroids. Saliva and urine tests at both labs use mass spectrometry. Diagnostic cut-offs set with older assays may be too high for newer ones.
RetestingCortisol varies a lot from day to day. For late-night saliva, within-person variation was 34.1% and a change of more than 104% between two samples was needed to be meaningful; across the day the salivary reference change value ranged from 96 to 245%.
Labcorp order code004051: Cortisol (serum)
Labcorp order code500179: Salivary Cortisol, LC/MS-MS
Labcorp order code004432: Cortisol, Urinary Free (24-hour urine)
Quest Diagnostics order code367: Cortisol, Total (serum)
Quest Diagnostics order code19897: Cortisol, LC/MS, Saliva
Quest Diagnostics order code11280: Cortisol, Free, 24-Hour Urine with Creatinine, LC/MS/MS
LOINC codes
  • 2143-6: Cortisol [Mass/volume] in Serum or Plasma
  • 9813-7: Cortisol [Mass/volume] in Serum or Plasma --AM peak specimen (morning blood sample)
  • 9812-9: Cortisol [Mass/volume] in Serum or Plasma --PM trough specimen (afternoon or evening blood sample)
  • 2142-8: Cortisol [Mass/volume] in Saliva (oral fluid) (salivary cortisol (Labcorp 500179, Quest 19897))
  • 2147-7: Cortisol Free [Mass/time] in 24 hour Urine (24-hour urine free cortisol (Labcorp 004432, Quest 11280))
LOINC 2143-6 on loinc.org

Sources: [2] [5] [13] [11] [106] [1] [14] [107] [108]

History

Cushing described the disease of cortisol excess in 1932. The isolation of adrenal steroids and the first use of cortisone in arthritis followed, and dynamic suppression and stimulation tests remain the basis of diagnosis.

  1. 1932Harvey Cushing describes basophil adenomas of the pituitary and their clinical picture ("pituitary basophilism"), now Cushing's disease. [109]
  2. 1949Hench, Kendall and colleagues report the effect of the adrenal hormone compound E (cortisone) and of ACTH on rheumatoid arthritis. [110]
  3. 1950Hench and colleagues publish the fuller report on cortisone and ACTH in rheumatoid arthritis, rheumatic fever and other conditions. [111]
  4. 1960Liddle describes tests of pituitary-adrenal suppressibility for diagnosing Cushing's syndrome. [112]
  5. 2008The Endocrine Society guideline recommends urine cortisol, late-night salivary cortisol or dexamethasone suppression as first tests for Cushing's syndrome. [20]
  6. 2016The Endocrine Society publishes its guideline on diagnosing and treating primary adrenal insufficiency. [23]
  7. 2021A study of newer cortisol assays proposes lower cosyntropin-test cut-offs (about 14.5-14.8 µg/dL) than the classic 18 µg/dL. [14]

FAQ

What is a normal cortisol level?

It depends on the time and the test. For morning blood, Labcorp's range is 6.2-19.4 µg/dL and Quest's (7-9 a.m.) 4.0-22.0 µg/dL; afternoon ranges are lower (Labcorp 2.3-11.9). Late-night saliva and 24-hour urine have their own ranges.

Sources: [2] [11]

When should a cortisol blood test be done?

Usually in the morning. Labcorp asks for blood at 8 a.m., and at 4 p.m. as well when the daily swing is being checked, because results must be read against the time of collection.

Sources: [2]

Do I need to fast for a cortisol test?

Neither Labcorp nor Quest lists a fasting requirement. For a saliva test, wait at least 60 minutes after eating, brushing your teeth or taking oral medicine before collecting.

Sources: [2] [11] [5]

Which is better: blood, saliva or urine cortisol?

They answer different questions. Blood cortisol, with a cosyntropin stimulation test, is used to check for adrenal insufficiency. Late-night saliva and 24-hour urine free cortisol are screening tests for Cushing's syndrome, because they pick up a loss of the night-time low or too much cortisol over a day.

Sources: [20] [14] [5] [13]

Can birth control or pregnancy raise cortisol?

Yes, total cortisol. Estrogen raises the cortisol-binding protein CBG, and Labcorp lists pregnancy, contraceptives and estrogen therapy as causes of high results. In one case report a woman on an estrogen pill had morning cortisol of 61 mcg/dL with a normal 24-hour urine free cortisol.

Sources: [2] [7] [19]

Does exercise raise cortisol?

Hard exercise does. In 12 trained men, 30 minutes at 60% and 80% of maximal oxygen uptake raised cortisol by 39.9% and 83.1%, while 40% barely changed it. Avoid hard training before a cortisol test.

Sources: [17]

Can supplements affect a cortisol test?

High-dose biotin can interfere with some immunoassays, so Labcorp asks people to stop biotin at least 72 hours before the sample. Prednisone and prednisolone cross-react with cortisol assays and give falsely high results.

Sources: [2] [11]

Is "adrenal fatigue" real?

A 2016 systematic review found no substantiation that "adrenal fatigue" is an actual medical condition; studies of salivary cortisol curves in people said to have it gave conflicting results. Real adrenal insufficiency is diagnosed with morning cortisol and a stimulation test.

Sources: [15] [22]

Do GH peptides raise cortisol?

Several do, briefly. Single doses of Hexarelin, GHRP-2, GHRP-6 and Ghrelin raised cortisol in human studies. With 16 weeks of twice-daily hexarelin the cortisol response fell rather than rose, and MK-677 (Ibutamoren) changed cortisol only after 2 years of daily use. Ipamorelin did not raise cortisol in pigs.

Sources: [37] [38] [32] [21] [29] [43] [100]

Does tesamorelin change cortisol?

Its label does not say. The Egrifta SV label reports no clinically significant changes in ACTH and other pituitary hormones, and gives no cortisol result. It also warns that growth hormone inhibits the enzyme that turns cortisone into cortisol, so people on steroid replacement may need higher doses.

Sources: [83]

How much does cortisol vary between tests?

A lot. In healthy people, late-night salivary cortisol varied by 34.1% within the same person, and a change of more than 104% between two samples was needed to be meaningful.

Sources: [107]

Why did my cortisol test come back with a different range from a friend's?

Different labs, methods and sample types have different ranges, and cut-offs set with older immunoassays may be too high for newer ones. Compare only with the range printed for your own test.

Sources: [14] [1]

References

  1. Vega-Beyhart A, Araujo-Castro M, Hanzu FA, et al. Cortisol: Analytical and clinical determinants. Adv Clin Chem. 2023;113:235-271. PMID 36858647
  2. Labcorp. Test 004051: Cortisol. Methodology, use, special instructions, limitations, specimen requirements, reference range and LOINC map. labcorp.com/tests/004051/cortisol
  3. ACTHAR GEL (repository corticotropin injection), prescribing information. DailyMed. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7b48ddec-e815-45f4-9ca0-5c0daaf56f30
  4. Clow A, Hucklebridge F, Stalder T, et al. The cortisol awakening response: more than a measure of HPA axis function. Neurosci Biobehav Rev. 2010;35(1):97-103. PMID 20026350
  5. Quest Diagnostics. Test code 19897: Cortisol, LC/MS, Saliva. Test directory entry (East region): collection instructions, clinical significance, reference ranges and LOINC. testdirectory.questdiagnostics.com/test/test-detail/19897/cortisol-lcms-saliva?cc=PHP
  6. Labcorp Specialty Testing (Esoterix). Test 500179: Salivary Cortisol, LC/MS-MS. Specimen requirements, methodology and reference interval. specialtytesting.labcorp.com/tests/500179/salivary-cortisol-lc-ms-ms
  7. Lewis JG, Bagley CJ, Elder PA, et al. Plasma free cortisol fraction reflects levels of functioning corticosteroid-binding globulin. Clin Chim Acta. 2005;359(1-2):189-94. PMID 15904907
  8. Hammond GL. Plasma steroid-binding proteins: primary gatekeepers of steroid hormone action. J Endocrinol. 2016;230(1):R13-25. PMID 27113851
  9. Purnell JQ, Brandon DD, Isabelle LM, et al. Association of 24-hour cortisol production rates, cortisol-binding globulin, and plasma-free cortisol levels with body composition, leptin levels, and aging in adult men and women. J Clin Endocrinol Metab. 2004;89(1):281-7. PMID 14715862
  10. Kuo T, McQueen A, Chen TC, et al. Regulation of Glucose Homeostasis by Glucocorticoids. Adv Exp Med Biol. 2015;872:99-126. PMID 26215992
  11. Quest Diagnostics. Test code 367: Cortisol, Total. Test directory entry (East region): methodology, specimen, collection notes, reference ranges and LOINC. testdirectory.questdiagnostics.com/test/test-detail/367/cortisol-total?cc=PHP
  12. Labcorp. Test 004432: Cortisol, Urinary Free (24-hour urine). Reference range by age and sex and LOINC map. labcorp.com/tests/004432/cortisol-urinary-free
  13. Quest Diagnostics. Test code 11280: Cortisol, Free, 24-Hour Urine with Creatinine, LC/MS/MS. Test directory entry (East region): reference ranges and LOINC. testdirectory.questdiagnostics.com/test/test-detail/11280/cortisol-free-24-hour-urine-with-creatinine-lcmsms?cc=PHP
  14. Javorsky BR, Raff H, Carroll TB, et al. New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays. J Endocr Soc. 2021;5(4):bvab022. PMID 33768189
  15. Cadegiani FA, Kater CE. Adrenal fatigue does not exist: a systematic review. BMC Endocr Disord. 2016;16(1):48. PMID 27557747
  16. van Dalfsen JH, Markus CR. The influence of sleep on human hypothalamic-pituitary-adrenal (HPA) axis reactivity: A systematic review. Sleep Med Rev. 2018;39:187-194. PMID 29126903
  17. Hill EE, Zack E, Battaglini C, et al. Exercise and circulating cortisol levels: the intensity threshold effect. J Endocrinol Invest. 2008;31(7):587-91. PMID 18787373
  18. Athanasiou N, Bogdanis GC, Mastorakos G. Endocrine responses of the stress system to different types of exercise. Rev Endocr Metab Disord. 2023;24(2):251-266. PMID 36242699
  19. Yu R. Exaggerated Increases in the Serum Cortisol Level in a Woman Following Oral Contraceptive Treatment. AACE Clin Case Rep. 2024;10(5):206-209. PMID 39372822
  20. Nieman LK, Biller BM, Findling JW, et al. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2008;93(5):1526-40. PMID 18334580
  21. Martins MR, Pinto AC, Brunner E, et al. GH-releasing peptide (GHRP-6)-induced ACTH release in patients with addison's disease: effect of glucocorticoid withdrawal. J Endocrinol Invest. 2003;26(2):143-7. PMID 12739742
  22. Charoensri S, Auchus RJ. A Contemporary Approach to the Diagnosis and Management of Adrenal Insufficiency. Endocrinol Metab (Seoul). 2024;39(1):73-82. PMID 38253474
  23. Bornstein SR, Allolio B, Arlt W, et al. Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101(2):364-89. PMID 26760044
  24. Colao A, Petersenn S, Newell-Price J, et al. A 12-month phase 3 study of pasireotide in Cushing's disease. N Engl J Med. 2012;366(10):914-24. PMID 22397653
  25. Troughton RW, Frampton CM, Lewis LK, et al. Differing thresholds for modulatory effects of adrenomedullin infusion on haemodynamic and hormone responses to angiotensin II and adrenocorticotrophic hormone in healthy volunteers. Clin Sci (Lond). 2001;101(1):103-9. PMID 11410122
  26. Ross JL, Schulte HM, Gallucci WT, et al. Ovine corticotropin-releasing hormone stimulation test in normal children. J Clin Endocrinol Metab. 1986;62(2):390-2. PMID 3001126
  27. Moro M, Putignano P, Losa M, et al. The desmopressin test in the differential diagnosis between Cushing's disease and pseudo-Cushing states. J Clin Endocrinol Metab. 2000;85(10):3569-74. PMID 11061503
  28. Scott LV, Medbak S, Dinan TG. ACTH and cortisol release following intravenous desmopressin: a dose-response study. Clin Endocrinol (Oxf). 1999;51(5):653-8. PMID 10594528
  29. Vestergaard ET, Andersen NH, Hansen TK, et al. Cardiovascular effects of intravenous ghrelin infusion in healthy young men. Am J Physiol Heart Circ Physiol. 2007;293(5):H3020-6. PMID 17873022
  30. Haass-Koffler CL, Long VM, Farokhnia M, et al. Intravenous administration of ghrelin increases serum cortisol and aldosterone concentrations in heavy-drinking alcohol-dependent individuals: Results from a double-blind, placebo-controlled human laboratory study. Neuropharmacology. 2019;158:107711. PMID 31310775
  31. Garin MC, Burns CM, Kaul S, et al. Clinical review: The human experience with ghrelin administration. J Clin Endocrinol Metab. 2013;98(5):1826-37. PMID 23533240
  32. Arvat E, Di Vito L, Lanfranco F, et al. Tyr-Ala-Hexarelin, a synthetic octapeptide, possesses the same endocrine activities of Hexarelin and GHRP-2 in humans. J Endocrinol Invest. 1999;22(2):91-7. PMID 10195374
  33. Arvat E, di Vito L, Maccagno B, et al. Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRH. Peptides. 1997;18(6):885-91. PMID 9285939
  34. Arimura H, Hashiguchi H, Yamamoto K, et al. Investigation of the clinical significance of the growth hormone-releasing peptide-2 test for the diagnosis of secondary adrenal failure. Endocr J. 2016;63(6):533-44. PMID 27020037
  35. Oliveira JH, Vieira JG, Abucham J, et al. GHRP-6 is able to stimulate cortisol and ACTH release in patients with Cushing's disease: comparison with DDAVP. J Endocrinol Invest. 2003;26(3):230-5. PMID 12809173
  36. Littley MD, Gibson S, White A, et al. Comparison of the ACTH and cortisol responses to provocative testing with glucagon and insulin hypoglycaemia in normal subjects. Clin Endocrinol (Oxf). 1989;31(5):527-33. PMID 2560684
  37. Ghigo E, Arvat E, Ramunni J, et al. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome. J Clin Endocrinol Metab. 1997;82(8):2439-44. PMID 9253314
  38. Rahim A, O'Neill PA, Shalet SM. The effect of chronic hexarelin administration on the pituitary-adrenal axis and prolactin. Clin Endocrinol (Oxf). 1999;50(1):77-84. PMID 10341859
  39. Maccario M, Veldhuis JD, Broglio F, et al. Impact of two or three daily subcutaneous injections of hexarelin, a synthetic growth hormone (GH) secretagogue, on 24-h GH, prolactin, adrenocorticotropin and cortisol secretion in humans. Eur J Endocrinol. 2002;146(3):310-8. PMID 11888836
  40. Contreras P, Araya V. Overnight dexamethasone pre-treatment improves the performance of the lysine-vasopressin test in the diagnosis of Cushing's syndrome. Clin Endocrinol (Oxf). 1996;44(6):703-10. PMID 8759183
  41. Copinschi G, Van Onderbergen A, L'Hermite-Balériaux M, et al. Effects of a 7-day treatment with a novel, orally active, growth hormone (GH) secretagogue, MK-677, on 24-hour GH profiles, insulin-like growth factor I, and adrenocortical function in normal young men. J Clin Endocrinol Metab. 1996;81(8):2776-82. PMID 8768828
  42. Murphy MG, Plunkett LM, Gertz BJ, et al. MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism. J Clin Endocrinol Metab. 1998;83(2):320-5. PMID 9467534
  43. Nass R, Pezzoli SS, Oliveri MC, et al. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial. Ann Intern Med. 2008;149(9):601-11. PMID 18981485
  44. Davis ME, Pemberton CJ, Yandle TG, et al. Urocortin-1 infusion in normal humans. J Clin Endocrinol Metab. 2004;89(3):1402-9. PMID 15001641
  45. Heuer JG, Meyer CM, Baker HE, et al. Pharmacological Evaluation of a Pegylated Urocortin-1 Peptide in Experimental Autoimmune Disease Models. J Pharmacol Exp Ther. 2022;382(3):287-298. PMID 35688476
  46. Degli Uberti EC, Trasforini G, Salvadori S, et al. Responses of plasma renin activity, aldosterone, adrenocorticotropin, and cortisol to dermorphin, a new synthetic potent opiate-like peptide, in man. J Clin Endocrinol Metab. 1983;57(6):1179-85. PMID 6313731
  47. Kokot F, Wiecek A, Schmidt-Gayk H, et al. Influence of long-term erythropoietin therapy on endocrine abnormalities in haemodialyzed patients. Przegl Lek. 1992;49(1-2):43-9. PMID 1455006
  48. Vanhorebeek I, Peeters RP, Vander Perre S, et al. Cortisol response to critical illness: effect of intensive insulin therapy. J Clin Endocrinol Metab. 2006;91(10):3803-13. PMID 16868064
  49. Nicolau J, Nadal A, Sanchís P, et al. Effects of liraglutide among patients living with psoriasis and obesity. Med Clin (Barc). 2023;161(7):293-296. PMID 37474395
  50. SIGNIFOR (pasireotide) injection, prescribing information. DailyMed. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a09a25fc-a5a3-0c82-e053-2995a90a5d74
  51. Garcia JM, Polvino WJ. Pharmacodynamic hormonal effects of anamorelin, a novel oral ghrelin mimetic and growth hormone secretagogue in healthy volunteers. Growth Horm IGF Res. 2009;19(3):267-73. PMID 19196529
  52. Suzuki S, Doi Y, Aoi W, et al. Effect of angiotensin III on blood pressure, renin-angiotensin-aldosterone system in normal and hypertensive subjects. Jpn Heart J. 1984;25(1):75-85. PMID 6376863
  53. Bjartell A, Ekman R, Bergquist S, et al. Reduction of immunoreactive ACTH in plasma following intravenous injection of delta sleep-inducing peptide in man. Psychoneuroendocrinology. 1989;14(5):347-55. PMID 2554357
  54. Späth-Schwalbe E, Schäfer A, Uthgenannt D, et al. Delta-sleep-inducing peptide does not affect CRH and meal-induced ACTH and cortisol secretion. Psychoneuroendocrinology. 1995;20(3):231-7. PMID 7777652
  55. Graf MV, Kastin AJ, Coy DH, et al. Delta-sleep-inducing peptide reduces CRF-induced corticosterone release. Neuroendocrinology. 1985;41(4):353-6. PMID 2995861
  56. Gianotti L, Ramunni J, Lanfranco F, et al. Recombinant human IGF-I does not modify the ACTH and cortisol responses to hCRH and hexarelin, a peptidyl GH secretagogue, in humans. J Endocrinol Invest. 2001;24(2):67-71. PMID 11263473
  57. Urwyler SA, Lustenberger S, Drummond JR, et al. Effects of oral macimorelin on copeptin and anterior pituitary hormones in healthy volunteers. Pituitary. 2021;24(4):555-563. PMID 33615399
  58. Overton CE, Kennedy SH, Egan DE, et al. The effect of nafarelin on human plasma adrenocorticotrophic hormone and cortisol concentrations. Hum Reprod. 1993;8(10):1593-7. PMID 8300812
  59. Pieters GF, Smals AG, Benraad TJ, et al. Plasma cortisol response to thyrotropin-releasing hormone and luteinizing hormone-releasing hormone in Cushing's disease. J Clin Endocrinol Metab. 1979;48(5):874-6. PMID 107184
  60. Van den Berghe G, de Zegher F, Baxter RC, et al. Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues. J Clin Endocrinol Metab. 1998;83(2):309-19. PMID 9467533
  61. Kovács DK, Farkas N, Soós A, et al. Assessment of clinical data on urocortins and their therapeutic potential in cardiovascular diseases: A systematic review and meta-analysis. Clin Transl Sci. 2021;14(6):2461-2473. PMID 34378854
  62. Schöneshöfer M, Oelkers W. Effect of prolonged infusions of angiotensin II on eight serum corticosteroids in man on different sodium diets. Horm Metab Res. 1980;12(11):614-20. PMID 7193170
  63. Semple PF, Buckingham JC, Mason PA, et al. Suppression of plasma ACTH concentration by angiotensin II infusion in normal humans and in a subject with a steroid 17 alpha-hydroxylase defect. Clin Endocrinol (Oxf). 1979;10(2):137-44. PMID 218750
  64. Perras B, Schultes B, Behn B, et al. Intranasal atrial natriuretic peptide acts as central nervous inhibitor of the hypothalamo-pituitary-adrenal stress system in humans. J Clin Endocrinol Metab. 2004;89(9):4642-8. PMID 15356075
  65. Ur E, Faria M, Tsagarakis S, et al. Atrial natriuretic peptide in physiological doses does not inhibit the ACTH or cortisol response to corticotrophin-releasing hormone-41 in normal human subjects. J Endocrinol. 1991;131(1):163-7. PMID 1660514
  66. Bierwolf C, Burgemeister A, Lüthke K, et al. Influence of exogenous atrial natriuretic peptide on the pituitary-adrenal response to corticotropin-releasing hormone and vasopressin in healthy men. J Clin Endocrinol Metab. 1998;83(4):1151-7. PMID 9543132
  67. Beyer HS, Parker L, Li CH, et al. Beta-endorphin attenuates the serum cortisol response to exogenous adrenocorticotropin. J Clin Endocrinol Metab. 1986;62(5):808-11. PMID 3007553
  68. Inder WJ, Livesey JH, Ellis MJ, et al. The effect of beta-endorphin on basal and insulin-hypoglycaemia stimulated levels of hypothalamic-pituitary-adrenal axis hormones in normal human subjects. Clin Endocrinol (Oxf). 1996;44(1):7-13. PMID 8706296
  69. Catlin DH, Poland RE, Gorelick DA, et al. Intravenous infusion of beta-endorphin increases serum prolactin, but not growth hormone or cortisol, in depressed subjects and withdrawing methadone addicts. J Clin Endocrinol Metab. 1980;50(6):1021-5. PMID 7372783
  70. Schulte HM, Allolio B. Infusion of beta-endorphin has no suppressive effect on the releasing hormone-stimulated pituitary-adrenal-axis of normal human subjects. Acta Endocrinol (Copenh). 1990;123(5):526-30. PMID 2175140
  71. Levchuk LA, Ivanova SA, Semke VY. Effects of neuroprotector cortexin on the dynamics of neuroendocrine system parameters in patients with organic emotionally labile (asthenic) disorders. Bull Exp Biol Med. 2013;155(1):75-7. PMID 23667876
  72. Antonijevic IA, Murck H, Bohlhalter S, et al. Neuropeptide Y promotes sleep and inhibits ACTH and cortisol release in young men. Neuropharmacology. 2000;39(8):1474-81. PMID 10818263
  73. Held K, Antonijevic I, Murck H, et al. Neuropeptide Y (NPY) shortens sleep latency but does not suppress ACTH and cortisol in depressed patients and normal controls. Psychoneuroendocrinology. 2006;31(1):100-7. PMID 16112814
  74. Woodhouse NJ, Dagogo-Jack S, Ahmed M, et al. Acute and long-term effects of octreotide in patients with ACTH-dependent Cushing's syndrome. Am J Med. 1993;95(3):305-8. PMID 8396322
  75. Julesz J, Vecsernyés M, Szász A, et al. [Effect of somatostatin-octreotide on secretion of adrenocorticotropin, cortisol and neuro-hypophyseal hormones in acromegaly]. Orv Hetil. 1998;139(51):3071-4. PMID 9914727
  76. Rieu M, Rosilio M, Richard A, et al. Paradoxical effect of somatostatin analogues on the ectopic secretion of corticotropin in two cases of small cell lung carcinoma. Horm Res. 1993;39(5-6):207-12. PMID 8314205
  77. Ditzen B, Schaer M, Gabriel B, et al. Intranasal oxytocin increases positive communication and reduces cortisol levels during couple conflict. Biol Psychiatry. 2009;65(9):728-31. PMID 19027101
  78. Gully BJ, Brown ZE, Hornbacher R, et al. Oxytocin Reduces Noradrenergic-Induced Opioid-Like Withdrawal Symptoms in Individuals on Opioid Agonist Therapy. Biol Psychiatry Glob Open Sci. 2025;5(1):100395. PMID 39534517
  79. Lewis DA, Sherman BM. Oxytocin does not influence adrenocorticotropin secretion in man. J Clin Endocrinol Metab. 1985;60(1):53-6. PMID 2981086
  80. Xu R, Zhao L, Liu J, et al. Natural Adrenocorticotropic Hormone (ACTH) Relieves Acute Inflammation in Gout Patients by Changing the Function of Macrophages. J Healthc Eng. 2022;2022:9241835. PMID 35646298
  81. CORTROSYN (cosyntropin) for injection 0.25 mg, prescribing information. DailyMed. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=746856e9-3930-4f6a-b8e6-a03845d6dd0b
  82. COSYNTROPIN for injection, prescribing information. DailyMed. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1342169c-e214-4f22-8363-1fd45b85d1e8
  83. EGRIFTA SV (tesamorelin for injection), prescribing information. DailyMed. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3d783378-b02d-4f19-99dd-0fc91a042224
  84. Newson MJ, Roberts EM, Pope GR, et al. The effects of apelin on hypothalamic-pituitary-adrenal axis neuroendocrine function are mediated through corticotrophin-releasing factor- and vasopressin-dependent mechanisms. J Endocrinol. 2009;202(1):123-9. PMID 19395447
  85. Smoday IM, Vukovic V, Oroz K, et al. Unilateral Adrenalectomy, and the Stable Pentadecapeptide BPC 157 as Therapy in Rats-A Cytoprotection Approach. Pharmaceuticals (Basel). 2026;19(6). PMID 42356491
  86. Charles CJ, Espiner EA, Richards AM, et al. Central C-type natriuretic peptide augments the hormone response to hemorrhage in conscious sheep. Peptides. 1995;16(1):129-32. PMID 7716064
  87. Zollers B, Rhodes L, Smith RG. Capromorelin increases food consumption, body weight, growth hormone, and sustained insulin-like growth factor 1 concentrations when administered to healthy adult Beagle dogs. J Vet Pharmacol Ther. 2017;40(2):140-147. PMID 27597271
  88. Taylor CC, Wu D, Soong Y, et al. Dynorphin A1-13 stimulates ovine fetal pituitary-adrenal function through a novel nonopioid mechanism. J Pharmacol Exp Ther. 1997;280(1):416-21. PMID 8996223
  89. Lu XY, Barsh GS, Akil H, et al. Interaction between alpha-melanocyte-stimulating hormone and corticotropin-releasing hormone in the regulation of feeding and hypothalamo-pituitary-adrenal responses. J Neurosci. 2003;23(21):7863-72. PMID 12944516
  90. Malendowicz LK, Warchol JB, Nussdorfer GG, et al. Effects of neurokinin-A on the rat hypothalamo-pituitary-adrenal axis. Endocr Res. 1995;21(4):757-67. PMID 8582326
  91. Al-Barazanji KA, Wilson S, Baker J, et al. Central orexin-A activates hypothalamic-pituitary-adrenal axis and stimulates hypothalamic corticotropin releasing factor and arginine vasopressin neurones in conscious rats. J Neuroendocrinol. 2001;13(5):421-4. PMID 11328451
  92. Kuru M, Ueta Y, Serino R, et al. Centrally administered orexin/hypocretin activates HPA axis in rats. Neuroreport. 2000;11(9):1977-80. PMID 10884055
  93. Gesto M, Soengas JL, Rodríguez-Illamola A, et al. Arginine vasotocin treatment induces a stress response and exerts a potent anorexigenic effect in rainbow trout, Oncorhynchus mykiss. J Neuroendocrinol. 2014;26(2):89-99. PMID 24341528
  94. Huffman LS, Hinz FI, Wojcik S, et al. Arginine vasotocin regulates social ascent in the African cichlid fish Astatotilapia burtoni. Gen Comp Endocrinol. 2015;212:106-13. PMID 24662391
  95. Shalts E, Feng YJ, Ferin M, et al. Alpha-melanocyte-stimulating hormone antagonizes the neuroendocrine effects of corticotropin-releasing factor and interleukin-1 alpha in the primate. Endocrinology. 1992;131(1):132-8. PMID 1319315
  96. Clark KA, Shin AC, Sirivelu MP, et al. Systemic administration of leptin decreases plasma corticosterone levels: role of hypothalamic norepinephrine. Brain Res. 2008;1195:89-95. PMID 18191822
  97. Le Cudennec C, Naudin B, Do Rego JC, et al. Nociceptin/orphanin FQ and related peptides reduce the increase in plasma corticosterone elicited in mice by an intracerebroventricular injection. Life Sci. 2002;72(2):163-71. PMID 12417250
  98. Mukhina AY, Mishina ES, Bobyntsev II, et al. Morphological Changes in the Large Intestine of Rats Subjected to Chronic Restraint Stress and Treated with Selank. Bull Exp Biol Med. 2020;169(2):281-285. PMID 32651826
  99. Svishcheva MV, Mishina YS, Medvedeva OA, et al. Morphofunctional State of the Large Intestine in Rats under Conditions of Restraint Stress and Administration of Peptide ACTH(4-7)-PGP (Semax). Bull Exp Biol Med. 2021;170(3):384-388. PMID 33459919
  100. Raun K, Hansen BS, Johansen NL, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552-61. PMID 9849822
  101. Goncharova ND, Khavinson BK, Lapin BA. Regulatory effect of Epithalon on production of melatonin and cortisol in old monkeys. Bull Exp Biol Med. 2001;131(4):394-6. PMID 11550036
  102. Mazzocchi G, Malendowicz LK, Rebuffat P, et al. Effects of galanin on the secretory activity of the rat adrenal cortex: in vivo and in vitro studies. Res Exp Med (Berl). 1992;192(6):373-81. PMID 1282728
  103. Tempel DL, Leibowitz SF. Galanin inhibits insulin and corticosterone release after injection into the PVN. Brain Res. 1990;536(1-2):353-7. PMID 1707723
  104. Prasad A, Naskar R, Dubey R, et al. Modulation of serum cortisol by substance P in albino rats: evidence of a direct effect on adrenal gland. Indian J Exp Biol. 2006;44(2):163-4. PMID 16480185
  105. Bagosi Z, Csabafi K, Palotai M, et al. The interaction of Urocortin II and Urocortin III with amygdalar and hypothalamic cotricotropin-releasing factor (CRF)--reflections on the regulation of the hypothalamic-pituitary-adrenal (HPA) axis. Neuropeptides. 2013;47(5):333-8. PMID 23932308
  106. LOINC 2143-6: Cortisol [Mass/volume] in Serum or Plasma. Regenstrief Institute. Record checked through the NLM Clinical Table Search Service. loinc.org/2143-6
  107. Casals G, Foj L, de Osaba MJ. Day-to-day variation of late-night salivary cortisol in healthy voluntaries. Clin Biochem. 2011;44(8-9):665-8. PMID 21320479
  108. Danese E, Padoan A, Negrini D, et al. Diurnal and day-to-day biological variation of salivary cortisol and cortisone. Clin Chem Lab Med. 2024;62(11):2287-2293. PMID 38721806
  109. Cushing H. The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). 1932. Obes Res. 1994;2(5):486-508. PMID 16353601
  110. HENCH PS, KENDALL EC. The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone; compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Proc Staff Meet Mayo Clin. 1949;24(8):181-97. PMID 18118071
  111. HENCH PS, KENDALL EC, SLOCUMB CH, et al. Effects of cortisone acetate and pituitary ACTH on rheumatoid arthritis, rheumatic fever and certain other conditions. Arch Intern Med (Chic). 1950;85(4):545-666. PMID 15411248
  112. LIDDLE GW. Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing's syndrome. J Clin Endocrinol Metab. 1960;20:1539-60. PMID 13761950

Educational information, not medical advice. Lab ranges and test codes were checked on October 29, 2026. Always use the range printed on your own report, and talk to a clinician about your results.